Murine autoimmune arthritis is exaggerated by infection with the rat tapeworm, Hymenolepis diminuta

International Journal for Parasitology

Volumn 43, Issue 7, 2013, Pages 593-601

  Graepel, Rabea ^a   Leung, Gabriella ^a   Wang, Arthur ^a   Villemaire, Michelle ^b   Jirik, Frank R ^b   Sharkey, Keith A ^a,c   McDougall, Jason J ^d   McKay, Derek M ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Complement; Inflammation; Mast cells; Parasitic helminth

Indexed keywords

BRINASE; COMPLEMENT COMPONENT C5A; EOSINOPHIL PEROXIDASE; MYELOPEROXIDASE;

DISEASE TREATMENT; EPIDEMIOLOGY; FLATWORM; IMMUNE RESPONSE; PARASITE;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRALGIA; ARTICLE; AUTOPSY; BLOOD ANALYSIS; CELL ACTIVATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTICERCOID; DISEASE EXACERBATION; DISEASE MODEL; ENZYME ACTIVITY; HYMENOLEPIASIS; HYMENOLEPIS DIMINUTA; INFLAMMATORY INFILTRATE; JOINT SWELLING; MALE; MAST CELL; MOUSE; NONHUMAN; POLYARTHRITIS; SYNOVITIS;

ANIMALS; ARTHRITIS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; HYMENOLEPIASIS; HYMENOLEPIS DIMINUTA; JOINTS; MALE; MICE; MICE, INBRED BALB C; PAIN;

ANIMALIA; HYMENOLEPIS DIMINUTA; MURINAE; MUS; VERMES;

EID: 84877109765     PISSN: 00207519     EISSN: 18790135     Source Type: Journal    
DOI: 10.1016/j.ijpara.2013.02.006     Document Type: Article

References (41)

1. Bach J.F. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 2002, 347:911-920.
2. Bogh H.O., Christensen J.P., Andreassen J. Complement-mediated lysis in vitro of newly excysted tapeworms: Hymenolepis diminuta, Hymenolepis microstoma, Hymenolepis nana and Hymenolepis citelli. Int. J. Parasitol. 1986, 16:157-161.
3. Correale J., Farez M.F. The impact of environmental infections (parasites) on MS activity. Mult. Scler. 2011, 17:1162-1169.
4. Dwinell M.B., Wise R.M., Bass P., Oaks J.A. Hymenolepis diminuta: mucosal mastocytosis and intestinal smooth muscle hypertrophy occur in tapeworm-infected rats. Exp. Parasitol. 1998, 89:92-102.
5. Feyerabend T.B., Weiser A., Tietz A., Stassen M., Harris N., Kopf M., Radermacher P., Moller P., Benoist C., Mathis D., Fehling H.J., Rodewald H.R. Cre-mediated cell ablation contests mast cell contribution in models of antibody- and T cell-mediated autoimmunity. Immunity 2011, 35:832-844.
6. Graepel R., Fernandes E.S., Aubdool A.A., Andersson D.A., Bevan S., Brain S.D. 4-oxo-2-nonenal (4-ONE): evidence of transient receptor potential ankyrin 1-dependent and -independent nociceptive and vasoactive responses in vivo. J. Pharmacol. Exp. Ther. 2011, 337:117-124.
7. Gause W.C., Urban J.F., Stadecker M.J. The immune response to parasitic helminths: insights from murine models. Trends Immunol. 2003, 24:269-277.
8. Guo R.F., Ward P.A. Role of C5a in inflammatory responses. Annu. Rev. Immunol. 2005, 23:821-852.
9. Arthritis in Canada an Ongoing Challenge 2003, Health Canada, Health Canada, Ottawa.
10. Honore P., Wismer C.T., Mikusa J., Zhu C.Z., Zhong C., Gauvin D.M., Gomtsyan A., El Kouhen R., Lee C.H., Marsh K., Sullivan J.P., Faltynek C.R., Jarvis M.F. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats. J. Pharmacol. Exp. Ther. 2005, 314:410-421.
11. Hunter M.M., Wang A., Hirota C.L., McKay D.M. Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically induced colitis. J. Immunol. 2005, 174:7368-7375.
12. Hunter M.M., Wang A., McKay D.M. Helminth infection enhances disease in a murine TH2 model of colitis. Gastroenterology 2007, 132:1320-1330.
13. Hunter M.M., Wang A., Parhar K.S., Johnston M.J., Van Rooijen N., Beck P.L., McKay D.M. In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice. Gastroenterology 2010, 138:1395-1405.
14. Jain R., Moreland L., Caldwell J., Rollins S., Mojcik C. A single dose, placebo controlled, double blind, phase I study of the humanized anti-C5 antibody h5G1in patients with rheumatoid arthritis. Arthritis Rheum. 1999, 42(S77).
15. Ji H., Ohmura K., Mahmood U., Lee D.M., Hofhuis F.M., Boackle S.A., Takahashi K., Holers V.M., Walport M., Gerard C., Ezekowitz A., Carroll M.C., Brenner M., Weissleder R., Verbeek J.S., Duchatelle V., Degott C., Benoist C., Mathis D. Arthritis critically dependent on innate immune system players. Immunity 2002, 16:157-168.
16. Keeble J., Russell F., Curtis B., Starr A., Pinter E., Brain S.D. Involvement of transient receptor potential vanilloid 1 in the vascular and hyperalgesic components of joint inflammation. Arthritis Rheum. 2005, 52:3248-3256.
17. Kneilling M., Hultner L., Pichler B.J., Mailhammer R., Morawietz L., Solomon S., Eichner M., Sabatino J., Biedermann T., Krenn V., Weber W.A., Illges H., Haubner R., Rocken M. Targeted mast cell silencing protects against joint destruction and angiogenesis in experimental arthritis in mice. Arthritis Rheum. 2007, 56:1806-1816.
18. Kuijk L.M., Klaver E.J., Kooij G., van der Pol S.M., Heijnen P., Bruijns S.C., Kringel H., Pinelli E., Kraal G., de Vries H.E., Dijkstra C.D., Bouma G., van Die I. Soluble helminth products suppress clinical signs in murine experimental autoimmune encephalomyelitis and differentially modulate human dendritic cell activation. Mol. Immunol. 2012, 51:210-218.
19. Kyburz D., Corr M. The KRN mouse model of inflammatory arthritis. Springer Semin. Immunopathol. 2003, 25:79-90.
20. Lee D.M., Friend D.S., Gurish M.F., Benoist C., Mathis D., Brenner M.B. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 2002, 297:1689-1692.
21. Matisz C.E., McDougall J.J., Sharkey K.A., McKay D.M. Helminth parasites and the modulation of joint inflammation. J. Parasitol. Res. 2011, 2011:e942616.
22. Mavers M., Cuda C.M., Misharin A.V., Gierut A.K., Agrawal H., Weber E., Novack D.V., Haines G.K. Cyclin-dependent kinase inhibitor p21, via its C-terminal domain, is essential for resolution of murine inflammatory arthritis. Arthritis Rheum. 2012, 64:141-152.
23. McKay D.M. The therapeutic helminth?. Trends Parasitol. 2009, 25:109-114.
24. McKay D.M. The immune response to and immunomodulation by Hymenolepis diminuta. Parasitology 2010, 137:385-394.
25. McKay D.M., Fairweather I., Johnston C.F., Shaw C., Halton D.W. Immunocytochemical and radioimmunometrical demonstration of serotonin- and neuropeptide-immunoreactivities in the adult rat tapeworm, Hymenolepis diminuta (cestoda, cyclophyllidea). Parasitology 1991, 103:275-289.
26. McLauchlan P.E., Roberts H.C., Loxton N.J., Wastling J.M., Newlands G.F., Chappell L.H. Mucosal mast cell responses and release of mast cell protease-I in infections of mice with Hymenolepis diminuta and Hymenolepis microstoma: modulation by cyclosporin A. Parasite Immunol. 1999, 21:151-161.
27. Monach P.A., Benoist C., Mathis D. The role of antibodies in mouse models of rheumatoid arthritis, and relevance to human disease. Adv. Immunol. 2004, 82:217-248.
28. Nigrovic P.A., Lee D.M. Synovial mast cells: role in acute and chronic arthritis. Immunol. Rev. 2007, 217:19-37.
29. Nigrovic P.A., Malbec O., Lu B., Markiewski M.M., Kepley C., Gerard N., Gerard C., Daeron M., Lee D.M. C5a receptor enables participation of mast cells in immune complex arthritis independently of Fcγ-receptor modulation. Arthritis Rheum. 2010, 62:3322-3333.
30. Okada H., Kuhn C., Feillet H., Bach J.F. The 'hygiene hypothesis' for autoimmune and allergic diseases: an update. Clin. Exp. Immunol. 2010, 160:1-9.
31. Osada Y., Shimizu S., Kumagai T., Yamada S., Kanazawa T. Schistosoma mansoni infection reduces severity of collagen-induced arthritis via down-regulation of pro-inflammatory mediators. Int. J. Parasitol. 2009, 39:457-464.
32. Pearson D.J., Taylor G. The influence of the nematode Syphacia oblevata on adjuvant arthritis in the rat. Immunology 1975, 29:391-396.
33. Reyes Hernandez J.-L., Leung G., McKay D.M. Cestode regulation of inflammation and inflammatory diseases. Int. J. Parasitol. 2013, 43:233-243.
34. Roberts L.A., Connor M. TRPV1 antagonists as a potential treatment for hyperalgesia. Recent Pat. CNS Drug Discovery 2006, 1:65-76.
35. Sadik C.D., Kim N.D., Iwakura Y., Luster A.D. Neutrophils orchestrate their own recruitment in murine arthritis through C5aR and FcγR signaling. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:E3177-3185.
36. Shi M., Wang A., Prescott D., Waterhouse C.C., Zhang S., McDougall J.J., Sharkey K.A., McKay D.M. Infection with an intestinal helminth parasite reduces Freund's complete adjuvant-induced monoarthritis in mice. Arthritis Rheum. 2011, 63:434-444.
37. Shin K., Nigrovic P.A., Crish J., Boilard E., McNeil H.P., Larabee K.S., Adachi R., Gurish M.F., Gobezie R., Stevens R.L., Lee D.M. Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes. J. Immunol. 2009, 182:647-656.
38. Trouw L.A., Haisma E.M., Levarht E.W., van der Woude D., Ioan-Facsinay A., Daha M.R., Huizinga T.W., Toes R.E. Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways. Arthritis Rheum. 2009, 60:1923-1931.
39. Tsuboi N., Ernandez T., Li X., Nishi H., Cullere X., Mekala D., Hazen M., Kohl J., Lee D.M., Mayadas T.N. Regulation of human neutrophil Fcγ-receptor IIa by C5a receptor promotes inflammatory arthritis in mice. Arthritis Rheum. 2011, 63:467-478.
40. Wang A., Fernando M., Leung G., Phan V., Smyth D., McKay D.M. Exacerbation of oxazolone colitis by infection with the helminth Hymenolepis diminuta: involvement of IL-5 and eosinophils. Am. J. Pathol. 2010, 177:2850-2859.
41. Whelan R.A., Hartmann S., Rausch S. Nematode modulation of inflammatory bowel disease. Protoplasma 2012, 249:871-886.